Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)

Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience

(2015) C. Chau et al.   ANNALS OF ONCOLOGY

Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists

(2015) Daniel M Berney et al.   HISTOPATHOLOGY

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group

(2014) T. Tandstad et al.   ANNALS OF ONCOLOGY

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

(2014) J. Aparicio et al.   ANNALS OF ONCOLOGY

A Nationwide Cohort Study of Stage I Seminoma Patients Followed on a Surveillance Program

(2014) Mette Saksø Mortensen et al.   EUROPEAN UROLOGY

Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance

(2014) Peter Chung et al.   Cancer Medicine

Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study

(2011) Jorge Aparicio et al.   JOURNAL OF CLINICAL ONCOLOGY

Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group

(2011) Torgrim Tandstad et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Trial of Carboplatin Versus Radiotherapy for Stage I Seminoma: Mature Results on Relapse and Contralateral Testis Cancer Rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214)

(2011) R. Timothy D. Oliver et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Trials in 2466 Patients With Stage I Seminoma: Patterns of Relapse and Follow-up

(2011) G. M. Mead et al.   JNCI-Journal of the National Cancer Institute